Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Author:

Yip Steven M.1ORCID,Wells Connor1ORCID,Moreira Raphael2,Wong Alex3,Srinivas Sandy4,Beuselinck Benoit5,Porta Camillo6,Sim Hao-Wen7ORCID,Ernst D. Scott8,Rini Brian I.9,Yuasa Takeshi10,Basappa Naveen S.3,Kanesvaran Ravindran11,Wood Lori A.12,Canil Christina13,Kapoor Anil14,Fu Simon Y.F.15,Choueiri Toni K.16ORCID,Heng Daniel Y.C.1

Affiliation:

1. Department of Medical Oncology; Tom Baker Cancer Center; Calgary Alberta Canada

2. Department of Oncology; Américas Medical Service/Brazil, United Health Group; Sao Paulo Brazil

3. Department of Medical Oncology, Cross Cancer Institute; University of Alberta; Edmonton Alberta Canada

4. Department of Medical Oncology; Stanford University; Stanford California

5. Department of General Medical Oncology; University Hospitals Leuven; Leuven Belgium

6. Department of Medical Oncology; IRCCS San Matteo University Hospital Foundation; Pavia Italy

7. Department of Medical Oncology; Princess Margaret Hospital; Toronto Ontario Canada

8. Department of Medical Oncology; London Health Sciences Centre; London Ontario Canada

9. Department of Oncology; Cleveland Clinic Taussig Cancer Institute; Cleveland Ohio

10. Department of Urology; Cancer Institute Hospital of Japanese Foundation for Cancer Research; Tokyo Japan

11. Department of Medical Oncology; National Cancer Centre Singapore; Singapore Singapore

12. Division of Medical Oncology; QEII Health Sciences Centre; Halifax Nova Scotia Canada

13. Division of Medical Oncology; University of Ottawa; Ottawa Ontario Canada

14. Division of Urology, Juravinski Cancer Centre; McMaster University; Hamilton Ontario Canada

15. Department of Medicine; Auckland City Hospital; Auckland New Zealand

16. Department of Medical Oncology; Dana-Farber Cancer Center; Boston Massachusetts

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3